Skip to content
NewsBlazeIN – Lifestyle
Author:
Nyxoah
Nyxoah Obtains Default Decision Against Inspire Medical Systems in Unified Patent Court Case
November 18, 2026
Nyxoah Reports Third Quarter 2026 Financial and Operating Results
November 5, 2026
Nyxoah to Release Third Quarter 2026 Financial Results on November 5, 2026
October 26, 2026
Nyxoah Announces Preliminary Results for the Third Quarter of 2026 and Adjusts Revenue Guidance for 2026
October 19, 2026
Full 12-Month Data from the ACCCESS U.S. Pivotal Study in Complete Concentric Collapse Patients Presented at ISSS 2026
October 15, 2026
Nyxoah Appoints Liam Kelly as Chief Executive Officer
September 28, 2026
Nyxoah Announces Chief Financial Officer Transition
September 21, 2026
Nyxoah Announces First Patient Implanted in BREATHE, the U.S. Post-Approval Study of the Genio® System
September 7, 2026
Nyxoah Announces ACCCESS U.S. Pivotal Study Meets Primary Safety and Efficacy Endpoints in Complete Concentric Collapse Patients
September 2, 2026
Information on the total number of voting rights and shares
August 25, 2026
1
2
3
Next Page
→